Squamous Cell Skin CarcinomaSymptoms, Doctors, Treatments, Advances & More
Squamous Cell Skin Carcinoma Overview
Learn About Squamous Cell Skin Carcinoma
Dana-Farber Cancer Institute, Center For Cutaneous Oncology
Chrysalyne Schmults is a Dermatologist practicing medicine in Boston, Massachusetts. Dr. Schmults is rated as an Elite provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Squamous Cell Skin Carcinoma, Basal Cell Skin Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), and Muir-Torre Syndrome. Dr. Schmults is board certified in Micrographic Dermatologic Surgery and Dermatology. Dr. Schmults is currently accepting new patients.
Cleveland Clinic Main Campus
Edward Maytin is a Dermatologist practicing medicine in Cleveland, Ohio. Dr. Maytin is rated as an Elite provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Actinic Keratosis, Squamous Cell Skin Carcinoma, Basal Cell Skin Cancer, and Nevoid Basal Cell Carcinoma Syndrome. Dr. Maytin is board certified in American Board Of Dermatology, 1990. Dr. Maytin is currently accepting new patients.
University Hospitals
Jeremy Bordeaux is a Dermatologist practicing medicine in Cleveland, Ohio. Dr. Bordeaux is rated as an Elite provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Squamous Cell Skin Carcinoma, Basal Cell Skin Cancer, Melanoma, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Bordeaux is currently accepting new patients.
Summary: The goal of this clinical trial is to learn if the combination of the drug cemiplimab along with a short course of radiation therapy called Quad Shot can be successfully given in several rounds to elderly or frail patients with head and neck skin cancers. The main question it aims to answer is: \- Can care providers successfully deliver at least 6 rounds of cemiplimab and 3 rounds of Quad Shot rad...
Summary: The goal of this study is to investigate the ability of a machine learning model to evaluate two-photon fluorescence microscopy images of dermatologic biopsies at point of care. The main question it aims to answer is: • How well do two-photon fluorescence images of biopsies taken in a clinic and evaluated by a machine learning model agree with conventional histology?

